Hyponatremia – Pipeline Review, H1 2012

Published : April 2012
No. of Pages : 37

Price:

Hyponatremia – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Hyponatremia - Pipeline Review, H1 2012', provides an overview of the Hyponatremia therapeutic pipeline. This report provides information on the therapeutic development for Hyponatremia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyponatremia. 'Hyponatremia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Hyponatremia.
- A review of the Hyponatremia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hyponatremia pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Hyponatremia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hyponatremia pipeline depth and focus of Hyponatremia therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hyponatremia Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hyponatremia 7
Hyponatremia Therapeutics under Development by Companies 9
Hyponatremia Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Hyponatremia Therapeutics – Products under Development by Companies 12
Hyponatremia Therapeutics – Products under Investigation by Universities/Institutes 13
Companies Involved in Hyponatremia Therapeutics Development 14
Cornerstone Therapeutics Inc. 14
Hyponatremia – Therapeutics Assessment 15
Assessment by Monotherapy Products 15
Assessment by Route of Administration 16
Assessment by Molecule Type 18
Drug Profiles 20
Lixivaptan - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Isotonic Parenteral Fluid - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Hypotonic Parenteral Fluid (Hamilton Health Sciences) - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Hyponatremia Therapeutics – Drug Profile Updates 26
Hyponatremia Therapeutics – Discontinued Products 27
Hyponatremia Therapeutics - Dormant Products 28
Hyponatremia – Product Development Milestones 29
Featured News & Press Releases 29
Mar 12, 2010: Seattle Genetics Expands Antibody-Drug Conjugate Patent Portfolio 29
Aug 03, 2009: The European Commission Approves Otsuka Pharmaceutical's Samsca (tolvaptan) For Hyponatremia 29
May 21, 2009: FDA Approves Otsuka Pharmaceutical's Samsca (tolvaptan) To Treat Patients With Clinically Significant Hypervolemic And Euvolemic Hyponatremia 30
Jun 25, 2008: U.S. Food And Drug Administration Advisory Committee Recommends Approval Of Tolvaptan, An Investigational Treatment For Hyponatremia 32
Dec 21, 2007: Otsuka Pharmaceutical's Files New Drug Application For Tolvaptan 32
Sep 19, 2007: ECLIPSE Data on Effects of Otsuka’s Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients’ Hemodynamics and Urine Output Featured in Heart Failure Society of America’s Late Breaking Trials 33
Mar 25, 2007: EVEREST Data on Short- and Long-Term Use of Otsuka’s Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC’s Late Breaking Clinical Trials 33
Dec 05, 2006: New Data On Otsuka's Investigational Product for Hyponatremia Presented at American Heart Association Annual Meeting Results of the SALT-1 and SALT-2 Trials Show Tolvaptan Improves Serum Sodium Levels in Patients with Hyponatremia 34
Nov 10, 2003: Otsuka’s Tolvaptan Shows Decreased Fluid Retention In Hospitalized Patients With Worsening Congestive Heart Failure Data on Novel Phase III Agent Presented at Late Breaking Clinical Trials Session During American Heart Association’s Scientific Sessions 2003 34
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Tables
Number of Products Under Development for Hyponatremia, H1 2012 7
Products under Development for Hyponatremia – Comparative Analysis, H1 2012 8
Number of Products under Development by Companies, H1 2012 9
Number of Products under Investigation by Universities/Institutes, H1 2012 10
Comparative Analysis by Late Stage Development, H1 2012 11
Products under Development by Companies, H1 2012 12
Products under Investigation by Universities/Institutes, H1 2012 13
Cornerstone Therapeutics Inc., H1 2012 14
Assessment by Monotherapy Products, H1 2012 15
Assessment by Stage and Route of Administration, H1 2012 17
Assessment by Stage and Molecule Type, H1 2012 19
Hyponatremia Therapeutics – Drug Profile Updates 26
Hyponatremia Therapeutics – Discontinued Products 27
Hyponatremia Therapeutics – Dormant Products 28

List of Figures
Number of Products under Development for Hyponatremia, H1 2012 7
Products under Development for Hyponatremia – Comparative Analysis, H1 2012 8
Products under Development by Companies, H1 2012 9
Products under Investigation by Universities/Institutes, H1 2012 10
Late Stage Products, H1 2012 11
Assessment by Monotherapy Products, H1 2012 15
Assessment by Route of Administration, H1 2012 16
Assessment by Stage and Route of Administration, H1 2012 17
Assessment by Molecule Type, H1 2012 18
Assessment by Stage and Molecule Type, H1 2012 19

Hyponatremia – Pipeline Review, H1 2012

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: